Table 1 |
|||||
|
Summary of reported findings and proportion of hospital deaths for all cancers and haematological malignancies. |
|||||
|
Study |
Country |
Dates of deaths |
Total patients (% hospital deaths) |
Main findings |
|
|
|
|||||
|
All cancers |
Haematological malignancy |
||||
|
|
|||||
|
Aabom, 2005 [12]* |
Denmark |
01/96-12/98 |
4,092 (70) |
129 (84) |
Compared to all other cancer deaths, patients dying from 'haematological' cancers (coding not specified) were more likely to die in institutions (hospital/nursing home). |
|
|
|||||
|
Bruera, 2002 [13]* |
USA |
09/97-08/98 |
1,466 (57) |
206 (84) |
Compared to all other cancer deaths, patients dying from 'hematologic' (coding not specified) were more likely to die in hospital. |
|
|
|||||
|
Bruera, 2003 [14]* |
USA |
09/96-08/98 |
13,577 (51) |
1,223 (NA) |
Compared to all other cancer deaths, patients dying from 'haematological' cancers (coding not specified) were more likely to die in hospital. |
|
|
|||||
|
Cardenas-Turanzas, 2006 [15]* |
USA |
1999-2000 |
866 (58) |
146 (79) |
Compared to all other cancer deaths, patients dying from 'leukaemia and lymphoma' were more likely to die in hospital than elsewhere (home/nursing home/hospice). |
|
|
|||||
|
Cohen, 2006 [16]* |
Belgium |
2001 |
15,0008 (54) |
1,109 (75) |
Compared to all other cancer deaths, patients dying from 'hematologic' cancers were more likely to die in hospital than home/care home/elsewhere. |
|
|
|||||
|
1Cohen, 2008 [17] * |
Belgium Netherlands Sweden Scotland England Wales |
2003 2003 2002 2003 2003 2003 |
14,632 (59) 38,181 (31) 21,294 (85) 15,145 (57) 127,346 (49) 8,419 (60) |
1,143 (71) 2,981 (47) 1,996 (91) 1,053 (74) 10,107 (70) 575 (78) |
Compared to all other cancer deaths, patients dying from 'hematologic malignancies' were more likely to die in hospital/care home than outside hospital. This was consistent across all countries included. |
|
|
|||||
|
Costantini, 1993 [18]* |
Italy |
01/86-12/90 |
12,315 (69) |
828 (79) |
Compared to all other cancer deaths, patients dying from 'leukaemia-lymphoma' were more likely to die in an institution (hospital/elderly care home). |
|
|
|||||
|
Costantini, 2000 [19]* |
Italy |
1991 |
17,597 (48) |
1,192 (64) |
Compared to all other specified cancer deaths, patients dying from cancers of the 'haemopoietic system' were more likely to die in a hospital/elderly care home. |
|
|
|||||
|
Davison, 2001 [20]* |
UK |
July-Dec 1977/87/97 |
1,324 (47) |
83 (75) |
Compared to all other cancer deaths, patients dying from cancer of the 'lymphatic' and 'haemopoietic tissue' were more likely to die in hospital and less likely to die in a hospice. |
|
|
|||||
|
Declich, 1991 [21]* |
Italy |
01/85-12/88 |
970 (18) |
112 (27) |
Compared to all other cancer deaths, patients dying from 'lymphoma' and 'haematopoietic neoplasms' were more likely to die in hospital (with the exception of colon cancer). |
|
|
|||||
|
Decker, 2006 [48] |
UK/USA |
1995-1998 |
UK 59,604 (56) USA 51,668 (74) |
NA |
Compared to all other cancer deaths, patients dying from cancer of the 'lymphatic' and 'haematopoietic' tissue aged ≥40 years were less likely to die at home (12% UK; 14% USA). |
|
|
|||||
|
Gatrell, 2003 [22]* |
UK |
1993-2000 |
6,900 (35) |
NA |
Compared to all other cancer deaths, patients dying from 'lymphatic system' cancer were more likely to die in hospital. |
|
|
|||||
|
Higginson, 1998 [23] |
UK |
1985-1994 |
1,344,187 (66) |
NA |
Compared to all other cancer deaths, patients dying from cancers of the 'lymphatic' or 'haematological system' were less likely to die at home. |
|
|
|||||
|
Hunt, 1996 [24]* |
Australia |
1990 |
2,800 (NA) |
260 (NA) |
Compared to all other cancer deaths, patients dying from 'haematological' cancers (coding not specified) were more likely to die in a Metropolitan Public Hospital. |
|
|
|||||
|
Hunt, 2001 [25]* |
Australia |
1990-1999 |
29,230 (55) |
3,045 (NA) |
Compared to all other cancer deaths, patients dying from 'lymphoma', 'multiple myeloma' and 'leukaemias' (coding not specified) were more likely to die in a Metropolitan Public Hospital. |
|
|
|||||
|
Lock, 2005 [26] |
UK |
1995-1999 |
315,462 (50) |
NA (66) |
Compared to all other cancer deaths, patients dying from 'lymphatic' and 'haematopoietic' cancers aged ≥75 years, were more likely to die in hospital and less likely to die in a hospice. |
|
|
|||||
|
McCusker, 1983 [27]* |
USA |
1976-1978 |
2,989 (70) |
315 (82) |
Compared to all other cancer deaths, patients dying from 'leukaemia and lymphoma' (coding not specified) were more likely to die in an acute care hospital. |
|
|
|||||
|
Polissar, 1987 [28]* |
USA |
1968-1981 |
22,456 (61) |
978 (73) |
Compared to other common cancers (9 selected cancer sites) patients with 'non-Hodgkin lymphoma' were the most likely to die in hospital. |
|
|
|||||
|
Roder, 1987 [29] |
Australia |
1981 & 1985 |
1,582 (37) |
NA (57) |
Compared to other common cancers (8 selected sites), patients with 'haematological malignancies' (leukaemia, lymphoma and myeloma) were more likely to die in a Metropolitan Public Hospital. |
|
|
|||||
|
Ross, 2007 [30]* |
UK |
1995-2000 |
31,812 (41) |
2,638 (62) |
Compared to all other cancer deaths, patients dying from haematological malignancy (all diagnoses combined) were more likely to die in hospital and less likely to die in a hospice. |
|
|
|||||
|
Saugo, 2008 [31]* |
Italy |
2004 |
350 (75) |
31 (87) |
Compared to all other cancer deaths, patients dying from 'haematological' cancers ≥50 years were more likely to die in hospital. |
|
|
|||||
|
1 Data on place of death only given for hospital and care home combined with the exception of Sweden, where care home is not a registered category. NA = not available; *Included in meta-analysis. |
|||||
|
Howell et al. BMC Palliative Care 2010 9:9 doi:10.1186/1472-684X-9-9 |
|||||